When you say FY24, I am guessing you talking about FY24 starting Jan 24 to Dec 24 (American not the Australian) , same as company reporting.
If you talking Jan 24 to Dec 24 then the first quarter revenue is only $11m so basically within next 3 quarter you are expecting it to make $64m or $21m per quarter? The approval just came in end of May so basically second quarter almost finished (1 month left) so they technical has 2 quarter left to show the performance !
Now, that is challenging growth of almost 50% from last financial year revenue.
Ann: AVITA Medical Announces FDA Approval of RECELL GO, page-24
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.42 |
Change
0.010(0.41%) |
Mkt cap ! $160.4M | |||
| Open | High | Low | Value | Volume |
| $2.42 | $2.45 | $2.41 | $562.3K | 231.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 82002 | $2.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.43 | 16 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| AVH (ASX) Chart |